APPLIED THERAPEUTICS INC (APLT)

US03828A1016 - Common Stock

0.7255  -0.08 (-9.54%)

Premarket: 0.7 -0.03 (-3.51%)

Buy % Consensus

82

ChartMill assigns a Buy % Consensus number of 82% to APLT. The Buy consensus is the weighted average rating of the current analysts ratings.

Analysts have set a mean price target forecast of 4.59. This target is 532.67% above the current price.
APLT was analyzed by 12 analysts. The buy percentage consensus is at 82. So analysts seem to be very confident about APLT.
In the last month the buy percentage fell by 5 points. So the trust of analysts is decreasing.
APLT was analyzed by 12 analysts, which is quite many. So the average rating should be quite meaningful.

Price Target & Forecast

Price Low Median Mean High 0.731.525.104.598.40 - 108.82% 602.96% 532.67% 1,057.82%
Up and Down Grades
Date Firm Action Rating
2024-12-23 William Blair Downgrade Outperform -> Market Perform
2024-12-20 RBC Capital Maintains Sector Perform -> Sector Perform
2024-12-02 UBS Downgrade Buy -> Neutral
2024-11-29 RBC Capital Downgrade Outperform -> Sector Perform
2024-11-29 Baird Maintains Outperform -> Outperform
2024-11-29 Citigroup Maintains Buy -> Buy
2024-09-19 Leerink Partners Maintains Outperform -> Outperform
2024-09-19 Citigroup Maintains Buy -> Buy
2024-08-27 Citigroup Maintains Buy -> Buy
2024-07-31 William Blair Initiate Outperform
2024-07-17 RBC Capital Reiterate Outperform -> Outperform
2024-04-11 RBC Capital Reiterate Outperform -> Outperform
2024-03-26 RBC Capital Initiate Outperform
2024-03-15 UBS Maintains Buy -> Buy
2024-03-06 UBS Maintains Buy -> Buy
2024-02-22 Leerink Partners Initiate Outperform
2024-02-16 Citigroup Maintains Buy -> Buy
2023-04-25 Baird Maintains Outperform
2023-04-05 Citigroup Maintains Buy
2022-08-17 Citigroup Maintains Buy
2022-08-16 Barclays Maintains Equal-Weight
2022-05-20 Citigroup Maintains Buy
2022-01-04 Barclays Downgrade Overweight -> Equal-Weight
2021-08-27 Goldman Sachs Downgrade Neutral -> Sell